(19)
(11)
EP 4 798 211 A1
(12)
(43)
Date of publication:
02.09.2026
Bulletin 2026/36
(21)
Application number:
24883287.5
(22)
Date of filing:
23.10.2024
(51)
International Patent Classification (IPC):
A61K
31/5517
(2006.01)
A61K
9/70
(2006.01)
A61K
9/00
(2006.01)
A61P
39/02
(2006.01)
(52)
Cooperative Patent Classification (CPC):
A61K
9/0056
;
A61K
9/006
;
A61K
9/0043
;
A61K
31/5517
;
A61K
45/06
(86)
International application number:
PCT/US2024/052674
(87)
International publication number:
WO 2025/090681
(
01.05.2025
Gazette 2025/18)
(84)
Designated Contracting States:
AL AT BE BG CH CY CZ DE DK EE ES FI FR GB GR HR HU IE IS IT LI LT LU LV MC ME MK MT NL NO PL PT RO RS SE SI SK SM TR
Designated Extension States:
BA
Designated Validation States:
GE KH MA MD TN
(30)
Priority:
23.10.2023
US 202363592568 P
(71)
Applicant:
Mithradote Bio, Inc.
San Diego, California 92121 (US)
(72)
Inventor:
LEE, Sophia
San Diego, California 92121 (US)
(74)
Representative:
Cooley (UK) LLP
22 Bishopsgate
London EC2N 4BQ
London EC2N 4BQ (GB)
(54)
RAPIDLY DEGRADING FORMULATIONS FOR REVERSING AN ATTEMPTED INCAPACITATION